Podcast Episodes
Back to SearchSecond-Generation Antipsychotics for OCD Augmentation
Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
11 hours ago
Are Z-Drugs Safe in the First Trimester of Pregnancy?
In this episode, we review a JAMA Psychiatry study of over 4 million pregnancies examining first-trimester Z-drug exposure and congenital malformatio…
5 days, 13 hours ago
Glutamatergic Augmentation in OCD
Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
1 week, 3 days ago
Schizophrenia: Which of Seven Antipsychotics Wins?
Faculty: Oliver Freudenreich, M.D.
Host: Flavio Guzmán, M.D.
2 weeks, 1 day ago
SSRI Dosing for OCD: Beyond FDA Guidelines
Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
2 weeks, 6 days ago
Trazodone for Insomnia and Comorbid Depression
In this episode, we explore a new meta-analysis reconciling trazodone's real-world reputation with cautious sleep medicine guidelines, examining its …
3 weeks, 4 days ago
Antipsychotics, Prolactin, and Sexual Side Effects
In this episode, we explore why antipsychotics cause hyperprolactinemia and sexual side effects, a leading reason patients quietly stop treatment. Dr…
1 month ago
EMERGENT-5: Cobenfy and Treatment Durability
In this episode, we sit down with Dr. Oliver Freudenreich to unpack EMERGENT-5, the year-long trial tracking Cobenfy's real-world durability and safe…
1 month ago
Antipsychotics and Weight Gain
In this episode, we sit down with Dr. Oliver Freudenreich to unpack antipsychotic-induced weight gain — why it happens, which medications carry the h…
1 month, 1 week ago
EPA vs. DHA: Fish Oil and Treatment-Resistant Depression
In this episode, we explore whether EPA, a specific omega-3 fatty acid, can help patients with treatment-resistant depression. Dr. Derick Vergne brea…
1 month, 2 weeks ago